A practical guide for providers on helping patients locate and fill Austedo prescriptions, navigate insurance, and avoid treatment gaps.
As a neurologist, psychiatrist, or movement disorder specialist prescribing Austedo (Deutetrabenazine), you know the drug works. What you may also know is that getting it into your patient's hands is often harder than it should be. Between specialty pharmacy requirements, prior authorization delays, and a cash price that exceeds $7,000 per month, your patients face real barriers to filling this prescription.
This guide offers a practical, step-by-step approach to helping your patients navigate the Austedo access landscape in 2026 — from locating stock to managing insurance and avoiding costly treatment interruptions.
Austedo is not in formal shortage as of early 2026. Teva Pharmaceuticals continues to manufacture both the immediate-release (twice daily) and extended-release (Austedo XR, once daily) formulations.
The access challenges patients face are structural:
For the full picture, see our clinical briefing on Austedo availability in 2026.
Understanding the patient experience helps you intervene more effectively:
Most patients first try their regular chain pharmacy. For a specialty drug like Austedo, the pharmacy typically doesn't carry it and tells the patient they need to order it or use a specialty pharmacy. The patient calls your office frustrated and confused.
Even after you submit a prescription, the insurance company may take 3 to 14 days to process a prior authorization. If step therapy is required, additional documentation showing previous treatment failure is needed. During this time, the patient is without medication.
Many patients have never used a specialty pharmacy and don't understand the different process — which may involve phone calls, enrollment, and home delivery rather than a quick pickup. Setting expectations early can reduce anxiety and prevent missed doses.
Don't wait until the patient has been titrated to their maintenance dose. Begin the PA process as soon as you decide to prescribe Austedo. This gives the insurer time to process while you're titrating, so the patient's access is secured by the time they reach their therapeutic dose.
Keep pre-built PA templates with supporting documentation:
Ask the patient's insurance which specialty pharmacies are in-network for Austedo. Common specialty pharmacy partners include Accredo, Express Scripts Specialty, CVS Specialty, and OptumRx Specialty. Send the prescription directly to the appropriate specialty pharmacy to avoid delays.
You can also use Medfinder for Providers to check real-time pharmacy stock and identify locations that currently have Austedo available.
Set clear expectations at the first visit:
This framing prevents confusion and empowers patients to be proactive about their refills.
If you have Austedo samples available, use them strategically to bridge the gap between prescribing and insurance approval. This is especially important during initial titration, when the patient is most at risk of losing momentum due to access delays.
Contact your Teva representative about sample availability for your practice.
Cost is a major barrier. Make sure patients know about:
Assign a staff member to help patients with enrollment. For more, see how to help patients save money on Austedo.
If Austedo access is consistently problematic for a patient, consider these alternatives:
Note that concurrent use of multiple VMAT2 inhibitors is contraindicated. Patients transitioning between agents need appropriate washout guidance.
For detailed alternative comparisons, see alternatives to Austedo.
Integrating Austedo access management into your practice workflow can reduce the burden on both you and your patients:
Assign one team member to manage specialty medication prior authorizations, track PA timelines, and follow up with specialty pharmacies. This person becomes the patient's point of contact for access questions.
Flag patients in your EHR who are on Austedo. If a patient misses an appointment or you learn of a refill problem, proactively reach out. Remember: missing more than one week requires re-titration from 6 mg/day, which adds weeks to reaching therapeutic effect.
Medfinder for Providers allows your staff to check pharmacy stock before the patient leaves the office. This means you can direct patients to a pharmacy that has Austedo available — rather than sending them out to search on their own.
Thorough documentation of treatment rationale, AIMS scores, and prior treatment history not only supports PA approvals but also prepares you for peer-to-peer reviews if initial PAs are denied.
Austedo is an effective medication for tardive dyskinesia and Huntington's chorea, and your patients shouldn't have to fight to fill their prescriptions. By proactively managing the prior authorization process, connecting patients with the right pharmacies and financial assistance programs, and using tools like Medfinder, you can significantly improve your patients' experience and reduce treatment interruptions.
For related clinical resources, explore:
This article is for informational purposes only and does not constitute medical advice. Clinical decisions should be made in consultation with the treating physician based on individual patient circumstances.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
